Purpose of the Procedure
- Detect large deletions and duplications in BRCA1 and BRCA2 genes.
- Assess hereditary risks for breast, ovarian, and related cancers.
- Provide critical genetic insights for family members regarding inherited risks.
Book BRCA MLPA Genetic Test | Lahalak Medical Platform
Protect your future with advanced genetic screening for breast and ovarian cancer risks. This MLPA analysis detects large genomic rearrangements missed by standard tests, providing critical insights for proactive health management.
Scientific name: BRCA1/2 Deletion and Duplication Analysis (MLPA)
An advanced genetic test detecting large deletions or duplications in BRCA1 and BRCA2 genes. It identifies hereditary cancer risks missed by standard sequencing, essential for comprehensive breast and ovarian cancer screening.
Service type
Genetic laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- MLPA laboratory analysis
- Genetic results report
Medical Service Information
Target Groups
- Individuals with a strong family history of breast or ovarian cancer.
- Patients with negative standard sequencing results but strong clinical suspicion.
- Anyone seeking a comprehensive assessment of genetic cancer predispositions.
Why MLPA Technology?
- It identifies 'Large Genomic Rearrangements' missed by standard sequencing methods.
- Gold standard for diagnosing copy number variations in genetic testing.
- Enables personalized preventive or therapeutic planning based on specific genetic findings.
Conditions & Notices
- Family medical history preferred
- Test is not affected by common medications
Medical services you might also like
